DVA DaVita Options Ahead of EarningsAnalyzing the options chain and the chart patterns of DVA DaVita prior to the earnings report this week,
I would consider purchasing the 175usd strike price Puts with
an expiration date of 2025-2-21,
for a premium of approximately $8.45.
If these options prove to be profitable prior to the earnings
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
11.03 USD
936.34 M USD
12.82 B USD
76.13 M
About DaVita Inc.
Sector
Industry
CEO
Javier J. Rodriguez
Website
Headquarters
Denver
Founded
1994
FIGI
BBG000MQ1SN9
DaVita, Inc. engages in the provision of medical care services. It operates through the following two segments: US Dialysis and Related Lab Services, and Other-Ancillary Services and Strategic Initiatives. The US Dialysis and Related Lab Services segment offers kidney dialysis services in the United States for patients suffering from chronic kidney failure. The Other-Ancillary Services and Strategic Initiatives segment consist primarily of pharmacy services, disease management services, vascular access services, clinical research programs, physician services, direct primary care, end stage renal disease seamless care organizations, and comprehensive care. The company was founded in 1994 and is headquartered in Denver, CO.
THC Tenet Healthcare Corp Financial
- Company has grown fast.
- Outperforming the market in general.
- Good outlook for the coming time.
Techinical
- Good risk-reward setup.
- Sector is in favor by many investors.
- Other stocks in the sector are just like this stock outperforming the market and I think this will co
DVA DaVita Inc (Long) Financial
- Company shows great results.
- Company passed the Hanhart fundamental growth test.
- Earnings + outlook + 10%.
- Growth outlook is one of the bests in these times.
Marco
- Company seems to perform well in most market conditions that are coming up.
Techincal
- Company is outpe
DaVita Inc. DaVita Inc. (NYSE: DVA) currently sits at a pivotal point, poised for potential growth. The RSI (14) is neutral at 43.97, indicating neither an overbought nor oversold condition. This neutrality often precedes a directional move, making DVA a prime candidate for a strategic entry.
The stock closed
DaVita (DVA) AnalysisLeading Dialysis Service Provider:
DaVita NYSE:DVA stands as a top kidney dialysis service provider in the U.S., demonstrating strong resilience post-COVID-19. CEO Javier Rodriguez emphasized the company's strengthened position and continued investments in staff and systems.
Expansive Market Pote
DVA LONG 041824I understand there may be some noise in the market regarding weight loss drugs, as such it has created a bit of a rift in prices of healthcare services relating to patient diets, lifestyles and procedures, could also be COVID lag/residue etc.
At this time however the Senior Living sector is expecte
DaVita (DVA) Stock Spike on Hope for Chronic Kidney Disease CureDaVita ( NYSE:DVA ) stock witnessed a significant surge as Novo Nordisk (NVO) unveiled promising results from its weight-loss drug study, offering newfound hope for patients battling chronic kidney disease. The groundbreaking findings have ignited investor optimism and reshaped the landscape for dia
A 80% edge - Mostly unused. Why?The Medianline/Pitchfork Tool provides a high probability (~80%) to reach the Centerline from any parallel line.
That means, if you can figure out how to buy as low as possible, or short as high as possible, your trade works out ~80% of time.
Why would one not use this edge?
Ask me questions, I
FlagEarnings 2-22 AMC.
Price has broken up from a triangle and looks to be forming a flag.
Earnings close and there has been some Medicare reimbursement issues which could affect earnings.
No recommendation.
EPS (FWD)
6.40
PE (FWD)
12.96
Div Rate (TTM)
-
Short Interest
3.04%
Market Cap
$7.47B
DaVita
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
DVA5026985
DaVita Inc. 3.75% 15-FEB-2031Yield to maturity
7.13%
Maturity date
Feb 15, 2031
DVA4994310
DaVita Inc. 4.625% 01-JUN-2030Yield to maturity
6.85%
Maturity date
Jun 1, 2030
DVA5876396
DaVita Inc. 6.875% 01-SEP-2032Yield to maturity
6.78%
Maturity date
Sep 1, 2032
See all DVA bonds
Related stocks
Frequently Asked Questions
The current price of DVA is 139.10 USD — it has increased by 2.40% in the past 24 hours. Watch DaVita Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NYSE exchange DaVita Inc. stocks are traded under the ticker DVA.
DVA stock has fallen by −6.01% compared to the previous week, the month change is a −7.44% fall, over the last year DaVita Inc. has showed a 4.58% increase.
We've gathered analysts' opinions on DaVita Inc. future price: according to them, DVA price has a max estimate of 186.00 USD and a min estimate of 145.00 USD. Watch DVA chart and read a more detailed DaVita Inc. stock forecast: see what analysts think of DaVita Inc. and suggest that you do with its stocks.
DVA stock is 3.89% volatile and has beta coefficient of 0.67. Track DaVita Inc. stock price on the chart and check out the list of the most volatile stocks — is DaVita Inc. there?
Today DaVita Inc. has the market capitalization of 10.80 B, it has decreased by −9.95% over the last week.
Yes, you can track DaVita Inc. financials in yearly and quarterly reports right on TradingView.
DaVita Inc. is going to release the next earnings report on May 13, 2025. Keep track of upcoming events with our Earnings Calendar.
DVA earnings for the last quarter are 2.24 USD per share, whereas the estimation was 2.13 USD resulting in a 5.35% surprise. The estimated earnings for the next quarter are 1.95 USD per share. See more details about DaVita Inc. earnings.
DaVita Inc. revenue for the last quarter amounts to 3.29 B USD, despite the estimated figure of 3.26 B USD. In the next quarter, revenue is expected to reach 3.21 B USD.
DVA net income for the last quarter is 259.33 M USD, while the quarter before that showed 214.69 M USD of net income which accounts for 20.79% change. Track more DaVita Inc. financial stats to get the full picture.
No, DVA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 23, 2025, the company has 76 K employees. See our rating of the largest employees — is DaVita Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. DaVita Inc. EBITDA is 2.68 B USD, and current EBITDA margin is 20.90%. See more stats in DaVita Inc. financial statements.
Like other stocks, DVA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade DaVita Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So DaVita Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating DaVita Inc. stock shows the buy signal. See more of DaVita Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.